表紙
市場調査レポート

肛門失禁 (便失禁):世界の治験動向

Anal Incontinence Global Clinical Trials Review, H1, 2015

発行 GlobalData 商品コード 330942
出版日 ページ情報 英文 49 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
肛門失禁 (便失禁):世界の治験動向 Anal Incontinence Global Clinical Trials Review, H1, 2015
出版日: 2015年04月28日 ページ情報: 英文 49 Pages
概要

当レポートでは、肛門失禁 (便失禁) に関する臨床研究の最新動向について分析しており、地域別の治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、各企業や研究機関における研究の進行状況、有望な薬剤の比較といった情報をまとめています。

イントロダクション

  • 肛門失禁
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:胃腸疾患治療薬の治験における肛門失禁の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

肛門失禁治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • S.L.A. Pharma AG
    • RDD Pharma Ltd.
    • Laboratoire HRA Pharma
  • 代表的な研究機関・病院の治験の概要
    • Centre Hospitalier Universitaire - Hopitaux de Rouen
    • Bezirkskrankenhaus Schwaz
    • Dalhousie University
    • Herlev Hospital
    • Pontificia Universidad Catolica de Chile
    • Uppsala University Hospital

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2653CTIDB

GlobalData's clinical trial report, "Anal Incontinence Global Clinical Trials Review, H1, 2015" provides data on the Anal Incontinence clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anal Incontinence. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anal Incontinence. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Anal Incontinence
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Anal Incontinence to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Anal Incontinence
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Anal Incontinence Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • S.L.A. Pharma AG
      • Clinical Trial Overview of S.L.A. Pharma AG
      • RDD Pharma Ltd.
      • Clinical Trial Overview of RDD Pharma Ltd.
      • Laboratoire HRA Pharma
      • Clinical Trial Overview of Laboratoire HRA Pharma
    • Clinical Trial Overview of Top Institutes / Government
      • Centre Hospitalier Universitaire - Hopitaux de Rouen
      • Clinical Trial Overview of Centre Hospitalier Universitaire - Hopitaux de Rouen
      • Bezirkskrankenhaus Schwaz
      • Clinical Trial Overview of Bezirkskrankenhaus Schwaz
      • Dalhousie University
      • Clinical Trial Overview of Dalhousie University
      • Herlev Hospital
      • Clinical Trial Overview of Herlev Hospital
      • Pontificia Universidad Catolica de Chile
      • Clinical Trial Overview of Pontificia Universidad Catolica de Chile
      • Uppsala University Hospital
      • Clinical Trial Overview of Uppsala University Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Anal Incontinence Therapeutics, Global, Clinical Trials by Region, 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Anal Incontinence to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Anal Incontinence Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Anal Incontinence Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by S.L.A. Pharma AG, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by RDD Pharma Ltd., 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoire HRA Pharma, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire - Hopitaux de Rouen, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Bezirkskrankenhaus Schwaz, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Dalhousie University, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Pontificia Universidad Catolica de Chile, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Uppsala University Hospital, 2015*

List of Figures

  • Anal Incontinence Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Anal Incontinence Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Anal Incontinence to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Anal Incontinence Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top